European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of …

D Taïeb, RJ Hicks, E Hindié, BA Guillet… - European journal of …, 2019 - Springer
Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

Personalized management for phaeochromocytomas and paragangliomas in Latin America: a genetic perspective

F Freitas-Castro, MQ Almeida - Best Practice & Research Clinical …, 2024 - Elsevier
Phaeochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors with
clinical heterogeneity and a high association with hereditary disease, affecting …

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

K Hadrava Vanova, Y Pang, L Krobova… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Pheochromocytoma and paraganglioma (PPGL) are neuroendocrine tumors
with frequent mutations in genes linked to the tricarboxylic acid cycle. However, no …

Update on the genetics of paragangliomas

AP Gimenez-Roqueplo, M Robledo… - Endocrine-related …, 2023 - erc.bioscientifica.com
Paragangliomas (PGL) of the adrenal (also known as pheochromocytomas) or extra-adrenal
neural crest-derived cells are highly heritable tumors, usually driven by single pathogenic …

Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation

Z Abdul Sater, A Jha, A Hamimi, A Mandl… - The Journal of …, 2020 - academic.oup.com
Abstract Context Pheochromocytomas/paragangliomas (PPGLs) are neuroendocrine tumors
that can secrete norepinephrine (NE). Brown adipose tissue (BAT) activation is mediated …

Recurrence-free survival analysis in locally advanced pheochromocytoma: first appraisal

S Moog, F Castinetti, C DoCao, L Amar… - The Journal of …, 2021 - academic.oup.com
Context The behavior of locally advanced pheochromocytoma (LAP) remains unknown.
Objective We characterized the population with LAP and recurrence-free survival (RFS) …

[HTML][HTML] Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma

S Albattal, M Alswailem, Y Moria, H Al-Hindi… - Oncotarget, 2019 - ncbi.nlm.nih.gov
Abstract About 30%–40% of patients with pheochromocytoma (PCC) and paraganglioma
(PGL) have underlying germline mutations in certain susceptibility genes despite absent …

Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells

L Streit, S Moog, S Hugel, M Rame, E Tanguy, V Andry… - Cancer Letters, 2022 - Elsevier
Increasingly common, neuroendocrine tumors (NETs) are regarded nowadays as
neoplasms potentially causing debilitating symptoms and life-threatening medical …

Mutation profile of aggressive pheochromocytoma and paraganglioma with comparison of TCGA data

YM Choi, J Lim, MJ Jeon, YM Lee, TY Sung, EG Hong… - Cancers, 2021 - mdpi.com
Simple Summary Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine
tumors arising from chromaffin cells of the adrenal medulla, or extra-adrenal paraganglia …

Serum fatty acid profiling in patients with SDHx mutations: new advances on cellular metabolism in SDH deficiency

J Vamecq, V Masso, LP Bancel, A Jannin, AF Dessein… - Biochimie, 2022 - Elsevier
Apart from the oncometabolite succinate, little studies have appeared on extra-mitochondrial
pathways in Succinate Dehydrogenase (SDH) genetic deficiency. The role of NADH/NAD+ …